Stock Analysis

McMillan Shakespeare (ASX:MMS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Investors were disappointed with McMillan Shakespeare Limited's (ASX:MMS) earnings, despite the strong profit numbers. We did some digging and found some worrying underlying problems.

View our latest analysis for McMillan Shakespeare

earnings-and-revenue-history
ASX:MMS Earnings and Revenue History September 2nd 2024
Advertisement

Examining Cashflow Against McMillan Shakespeare's Earnings

In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). To get the accrual ratio we first subtract FCF from profit for a period, and then divide that number by the average operating assets for the period. The ratio shows us how much a company's profit exceeds its FCF.

Therefore, it's actually considered a good thing when a company has a negative accrual ratio, but a bad thing if its accrual ratio is positive. While it's not a problem to have a positive accrual ratio, indicating a certain level of non-cash profits, a high accrual ratio is arguably a bad thing, because it indicates paper profits are not matched by cash flow. To quote a 2014 paper by Lewellen and Resutek, "firms with higher accruals tend to be less profitable in the future".

McMillan Shakespeare has an accrual ratio of 0.49 for the year to June 2024. Statistically speaking, that's a real negative for future earnings. To wit, the company did not generate one whit of free cashflow in that time. In the last twelve months it actually had negative free cash flow, with an outflow of AU$128m despite its profit of AU$90.1m, mentioned above. We saw that FCF was AU$8.3m a year ago though, so McMillan Shakespeare has at least been able to generate positive FCF in the past.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On McMillan Shakespeare's Profit Performance

As we discussed above, we think McMillan Shakespeare's earnings were not supported by free cash flow, which might concern some investors. As a result, we think it may well be the case that McMillan Shakespeare's underlying earnings power is lower than its statutory profit. But at least holders can take some solace from the 64% per annum growth in EPS for the last three. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. While conducting our analysis, we found that McMillan Shakespeare has 3 warning signs and it would be unwise to ignore these.

Today we've zoomed in on a single data point to better understand the nature of McMillan Shakespeare's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

โ€ข Connect an unlimited number of Portfolios and see your total in one currency
โ€ข Be alerted to new Warning Signs or Risks via email or mobile
โ€ข Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About ASX:MMS

McMillan Shakespeare

Provides salary packaging, novated leasing, disability plan management, support co-ordination, asset management, and related financial products and services in Australia and New Zealand.

Fair value with mediocre balance sheet.

Similar Companies

Advertisement

Weekly Picks

AL
RKLB logo
AlexLovell on Rocket Lab ยท

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25380.9% overvalued
69 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative
AG
Agricola
EXN logo
Agricola on Excellon Resources ยท

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.4% undervalued
69 users have followed this narrative
10 users have commented on this narrative
20 users have liked this narrative
FU
FundamentallySarcastic
CCP logo
FundamentallySarcastic on Credit Corp Group ยท

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08

Fair Value:AU$12.6410.4% overvalued
11 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative

Updated Narratives

BA
NVO logo
bactrian on Novo Nordisk ยท

A Quality Compounder Marked Down on Overblown Fears

Fair Value:US$9542.0% undervalued
95 users have followed this narrative
8 users have commented on this narrative
0 users have liked this narrative
YI
ETSY logo
yiannisz on Etsy ยท

Etsy Stock: Defending Differentiation in a World of Infinite Marketplaces

Fair Value:US$64.459.1% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YI
ALGN logo
yiannisz on Align Technology ยท

Align Technology Stock: Premium Orthodontics in a Cost-Sensitive World

Fair Value:US$154.623.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

AG
Agricola
EXN logo
Agricola on Excellon Resources ยท

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.4% undervalued
69 users have followed this narrative
10 users have commented on this narrative
20 users have liked this narrative
AL
RKLB logo
AlexLovell on Rocket Lab ยท

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25380.9% overvalued
69 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ยท

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0225.6% undervalued
1020 users have followed this narrative
6 users have commented on this narrative
28 users have liked this narrative